Press Releases May 11, 2026 04:05 PM

Amwell® to Participate in Upcoming Investor Conference

Amwell to present at 21st Annual Needham Technology, Media & Consumer Conference

By Hana Yamamoto
Share
Twitter Reddit Facebook LinkedIn
AMWL

Amwell announced that CFO and COO Mark Hirschhorn will participate in a virtual presentation at the upcoming Needham Technology, Media & Consumer Conference on May 14, showcasing the company's SaaS-based healthcare platform.

Amwell® to Participate in Upcoming Investor Conference
AMWL
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Amwell is a leading provider of SaaS-based technology-enabled healthcare platforms.
  • The company serves major healthcare organizations in the US and internationally with integrated clinical program solutions.
  • Participation in the Needham conference provides a platform to highlight Amwell's technology and growth strategy to investors.

BOSTON, May 11, 2026 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, today announced that Mark Hirschhorn, CFO and COO, will participate in the 21st Annual Needham Technology, Media & Consumer Conference, taking place virtually on May 14, including a presentation at 2:15 p.m. ET. An audio webcast of the fireside chat will be available at investors.amwell.com.

About Amwell

Amwell offers payers and health systems a single, comprehensive, technology-enabled care platform. We use technology to provide patients with better access to more convenient, affordable and effective care. The Amwell platform includes software and services that power many clinical programs from Amwell and our growing number of partners. Our platform allows patients to experience unified, personalized and simple access to diversified clinical programs across the care continuum. As more people seek care online and more clinical programs become available, we offer integrated, future-ready, consistent solutions. The Amwell platform is proven, operating at a large scale, enabling care for millions of patients and their sponsors while delivering dependable outcomes. For almost two decades, Amwell has proudly served some of the largest and most sophisticated healthcare organizations in the U.S. and worldwide. For more information, visit business.amwell.com or LinkedIn.

Contacts

Media:
press@amwell.com

Investors:
Asher Dewhurst
amwell@icrhealthcare.com 


Risks

  • Market competition in the digital health technology sector remains intense, potentially impacting growth.
  • Dependence on adoption of telehealth and SaaS platforms by healthcare providers could affect future revenue.
  • Regulatory changes in healthcare and telemedicine could introduce operational challenges.

More from Press Releases

Magnera Announces the Sale of Its Caerphilly, United Kingdom Operations Jun 15, 2026 IQE and Tower Semiconductor Announce Multi-year InP epiwafer Supply Agreement Jun 15, 2026 VAALCO Energy, Inc. Announces Exciting Operational Update in Offshore Gabon and in Egypt Jun 15, 2026 Ascentage Pharma Presents Multiple Clinical Updates at EHA2026 Congress Jun 14, 2026 Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026 Jun 14, 2026